Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › GA › Americus › NPI 1609001312
Hospital

Phoebe Sumter Medical Center, INC.

Phoebe Sumter Medical Center, INC. was paid $16.49M by Medicaid between Jan 2018 and Dec 2024, across 248 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoPHOEBE SUMTER MEDICAL CENTER, INC.
AMERICUS, GA 31719
33aNPI1609001312assigned 05/26/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.49M
24GClaims588,776
24DCodes billed248
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Georgia

Rank by total paid#4 of 34
Median peer was paid$23K
This provider vs. median715×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201889,074$2.66M
201995,356$2.51M
202078,352$1.96M
202187,023$2.31M
202290,993$2.70M
202387,492$2.59M
2024incomplete60,486$1.77M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 33,714 31,266 $2.79M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.4% 23,774 21,522 $1.56M
74177 Computed tomography, abdomen and pelvis; with contrast material 7.6% 3,018 2,845 $1.26M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.7% 6,106 5,528 $781K
70450 Computed tomography, head or brain; without contrast material 4.1% 3,970 3,679 $679K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.3% 7,232 5,437 $547K
96361 Intravenous infusion, hydration; each additional hour 3.1% 7,361 5,902 $516K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.9% 1,611 1,522 $471K
96375 Therapeutic injection; each additional sequential IV push 2.8% 10,723 8,086 $467K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.6% 7,643 7,001 $423K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 10,416 8,810 $356K
G0378 Hospital observation service, per hour 1.8% 3,933 1,851 $303K
236 more codes
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.8% 13,455 $292K
80053 Comprehensive metabolic panel 1.6% 35,886 $261K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.6% 1,310 $257K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.5% 1,298 $240K
71045 Radiologic examination, chest; single view 1.4% 8,127 $224K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.3% 5,048 $222K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.3% 10,516 $206K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 38,017 $203K
99213 Doctor's office visit, returning patient (routine) 1.2% 2,847 $192K
87428 1.1% 3,002 $180K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.1% 2,361 $176K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.0% 362 $169K
71046 Radiologic examination, chest; 2 views <1% 4,918 $155K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,965 $141K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,603 $140K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,781 $129K
96367 <1% 2,313 $129K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 13,102 $127K
96376 <1% 3,473 $126K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,283 $124K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,499 $112K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,998 $101K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 289 $91K
72125 Computed tomography, cervical spine; without contrast material <1% 322 $73K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,557 $71K
83880 <1% 2,795 $62K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 355 $60K
84443 Thyroid stimulating hormone (TSH) <1% 4,214 $58K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,252 $57K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 720 $50K
84484 <1% 6,421 $49K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,466 $44K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,906 $44K
87430 <1% 5,258 $42K
82553 <1% 4,791 $42K
73562 <1% 990 $42K
81025 <1% 6,931 $40K
81001 <1% 16,145 $39K
36591 <1% 4,438 $39K
74018 <1% 1,406 $38K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,590 $37K
87070 <1% 5,522 $34K
83735 <1% 8,221 $34K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 7,471 $32K
80048 Basic metabolic panel (calcium, ionized) <1% 5,697 $31K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,590 $31K
59025 Fetal non-stress test <1% 369 $29K
97162 <1% 1,326 $29K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,255 $28K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 507 $28K
88312 <1% 575 $27K
80320 <1% 1,658 $27K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 488 $26K
80061 Lipid panel <1% 2,798 $26K
87040 <1% 2,635 $25K
73030 <1% 660 $25K
82803 <1% 1,669 $25K
87631 <1% 617 $24K
73630 <1% 463 $23K
82948 <1% 7,953 $23K
73610 <1% 566 $23K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,629 $21K
99214 Doctor's office visit, returning patient (more involved) <1% 318 $21K
82728 <1% 2,576 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 143 $21K
85027 <1% 5,242 $21K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,474 $19K
96368 <1% 518 $19K
APT15 <1% 1,906 $19K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,162 $19K
83690 <1% 3,745 $19K
64450 <1% 721 $19K
82607 <1% 1,743 $18K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 109 $18K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 78 $18K
84466 <1% 2,352 $17K
76641 <1% 390 $17K
J1815 Injection, insulin, per 5 units <1% 1,429 $17K
86850 <1% 1,776 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,254 $16K
82550 <1% 5,498 $16K
93971 <1% 190 $16K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 43 $16K
83036 Hemoglobin; glycosylated (A1C) <1% 1,825 $15K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 45 $15K
97803 <1% 1,023 $15K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 602 $14K
71250 <1% 162 $13K
86140 <1% 2,640 $13K
36600 <1% 1,643 $13K
97116 <1% 2,669 $13K
86901 <1% 1,991 $12K
87512 <1% 255 $12K
87077 <1% 1,704 $11K
87186 <1% 1,646 $11K
83605 <1% 1,505 $11K
96523 <1% 590 $11K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,072 $11K
72100 <1% 283 $10K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,505 $10K
73130 <1% 233 $10K
83540 <1% 2,401 $9K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 938 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 12,513 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,720 $9K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 315 $9K
J0897 Injection, denosumab, 1 mg <1% 28 $9K
85730 <1% 2,351 $8K
85610 <1% 3,272 $8K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,075 $8K
J1756 Injection, iron sucrose, 1 mg <1% 407 $8K
82746 <1% 924 $7K
36415 Collection of venous blood by venipuncture <1% 23,021 $6K
87807 <1% 620 $6K
81003 <1% 4,238 $6K
86900 <1% 2,242 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,366 $6K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,449 $6K
88304 <1% 259 $6K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 544 $5K
73502 <1% 197 $5K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,675 $5K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,473 $5K
84702 <1% 659 $4K
97161 <1% 499 $4K
76801 <1% 44 $4K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,041 $4K
85379 <1% 590 $4K
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,033 $4K
96417 <1% 44 $4K
85651 <1% 1,104 $4K
76642 <1% 78 $4K
J2060 Injection, lorazepam, 2 mg <1% 1,014 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 1,378 $3K
84439 <1% 408 $3K
87899 <1% 266 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 14 $3K
73110 <1% 69 $3K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 243 $3K
86703 <1% 173 $2K
99460 <1% 28 $2K
80076 <1% 317 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 5,419 $2K
APT17 <1% 157 $2K
90715 <1% 133 $2K
94060 <1% 14 $2K
74019 <1% 69 $2K
87481 <1% 40 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 147 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,808 $2K
82565 <1% 711 $2K
73560 <1% 58 $2K
99238 Hospital discharge day management, 30 minutes or less <1% 30 $2K
0240U <1% 13 $2K
88313 <1% 51 $2K
73221 <1% 13 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 655 $2K
97535 Self-care/home management training, each 15 minutes <1% 411 $1K
83718 <1% 126 $1K
96415 <1% 40 $1K
93017 <1% 29 $1K
84436 <1% 235 $1K
94618 <1% 31 $1K
99406 <1% 709 $1K
85045 <1% 324 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 2,159 $1K
83615 <1% 456 $1K
84479 <1% 204 $1K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 304 $1K
APT16 <1% 74 $985.32
97802 <1% 25 $969.66
83520 <1% 82 $948.92
51702 <1% 46 $942.00
80329 <1% 29 $922.14
J1650 Injection, enoxaparin sodium, 10 mg <1% 314 $919.46
J0561 Injection, penicillin g benzathine, 100,000 units <1% 17 $885.02
82784 <1% 84 $834.78
86923 <1% 59 $828.81
96411 <1% 19 $763.31
J1644 Injection, heparin sodium, per 1000 units <1% 1,199 $723.61
82570 <1% 188 $679.82
77065 Tomosynthesis, mammo <1% 16 $676.16
84145 <1% 206 $674.50
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 836 $638.72
76937 <1% 15 $636.64
84520 <1% 312 $551.08
36430 <1% 33 $536.33
72081 <1% 12 $461.74
P9016 Red blood cells, leukocytes reduced, each unit <1% 16 $456.11
J7510 Prednisolone oral, per 5 mg <1% 129 $453.37
J3370 Injection, vancomycin hcl, 500 mg <1% 61 $439.22
83655 <1% 39 $426.87
76770 <1% 14 $417.01
87799 <1% 52 $404.44
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 28 $388.35
97032 <1% 65 $375.03
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 130 $354.61
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 32 $328.28
84153 <1% 27 $312.63
86696 <1% 12 $295.39
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 62 $285.06
J1953 Injection, levetiracetam, 10 mg <1% 13 $283.85
82274 <1% 14 $258.76
87400 <1% 39 $241.30
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 15 $203.32
86695 <1% 12 $201.24
82947 <1% 43 $195.02
86592 <1% 42 $176.04
87147 <1% 51 $162.00
J1630 Injection, haloperidol, up to 5 mg <1% 168 $154.19
87205 <1% 74 $151.03
J1940 Injection, furosemide, up to 20 mg <1% 432 $146.07
86038 <1% 13 $143.27
J2785 Injection, regadenoson, 0.1 mg <1% 15 $141.36
J1171 Injection, hydromorphone, 0.1 mg <1% 69 $140.12
J3480 Injection, potassium chloride, per 2 meq <1% 154 $123.45
84100 <1% 58 $79.97
81002 <1% 26 $79.44
85018 <1% 49 $78.78
84450 <1% 13 $77.85
82272 <1% 28 $76.65
84460 <1% 12 $71.50
82043 <1% 15 $54.55
84156 <1% 17 $49.70
J0780 Injection, prochlorperazine, up to 10 mg <1% 12 $48.56
84550 <1% 13 $47.62
85014 <1% 36 $46.59
J0360 Injection, hydralazine hcl, up to 20 mg <1% 12 $33.16
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 840 $23.80
84155 <1% 24 $18.35
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 36 $17.19
A9270 Non-covered item or service <1% 5,254 $0.34
V2632 Posterior chamber intraocular lens 0% 109 $0.00
P9612 Catheterization for collection of specimen, single patient, all places of service 0% 13 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 189 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLOUDERMILK, KERRY (SR. VP / CFO)